Shandong Wohua Pharmaceutical Co., Ltd. (SHE:002107)
6.12
0.00 (0.00%)
Oct 23, 2026, 3:04 PM CST
SHE:002107 Revenue
Shandong Wohua Pharmaceutical had revenue of 195.49M CNY in the quarter ending September 30, 2026, a decrease of -1.89%. This brings the company's total for the last twelve months to 781.18M, down -3.76% year-over-year. In the year 2025, Shandong Wohua Pharmaceutical had annual revenue of 816.95M with 6.96% growth. That makes Shandong Wohua Pharmaceutical the 21,465th largest company in the world by revenue and 3,938th in China.
Revenue (ttm)
781.18M
Revenue Growth
-3.76%
P/S Ratio
4.52
Revenue / Employee
767.37K
Employees
1,018
Market Cap
3.53B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 816.95M | 53.16M | 6.96% |
| Dec 31, 2024 | 763.79M | -145.71M | -16.02% |
| Dec 31, 2023 | 909.51M | -105.31M | -10.38% |
| Jan 1, 2023 | 1.01B | 72.14M | 7.65% |
| Jan 1, 2022 | 942.67M | -63.41M | -6.30% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Shenzhen Neptunus Bioengineering | 23.66B |
| Jinhe Biotechnology CO., LTD. | 2.94B |
| Zhejiang Starry Pharmaceutical | 2.46B |
| Henan Taloph Pharmaceutical Stock Co.,Ltd | 1.73B |
| Nanjing Well Pharmaceutical Group | 1.40B |
| Tibet Weixinkang Medicine | 1.13B |
| PKU HealthCare Corp.,Ltd. | 972.17M |
| ChengDu ShengNuo Biotec | 911.15M |